Definium Therapeutics Inc. Common Shares vs Teucrium Soybean Fund — how do they compare? Definium Therapeutics Inc. Common Shares trades at $34.01 (market cap $4.71B), while Teucrium Soybean Fund trades at $27.42 (market cap $43.67M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 107.9× Teucrium Soybean Fund's market cap, and Teucrium Soybean Fund is trading nearer its 52-week high, Definium Therapeutics Inc. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Teucrium Soybean Fund for 23 Days on average.
| DFTX | SOYB | |
|---|---|---|
Market Cap | $4.71B | $43.67M |
Volume | 1,966,636 | 52,528 |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $48.45 | $28.14 |
52-Week Low | $10.68 | $21.55 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $3.67B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →